期刊
VACCINE
卷 28, 期 29, 页码 4653-4660出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2010.04.069
关键词
Staphylococcus aureus; Vaccine; Economics
资金
- Bill and Melinda Gates Foundation
- National Institute of General Medical Sciences Models of Infectious Disease Agent Study (MIDAS) [1U54GM088491-0109]
- Pennsylvania Department of Health
- Vaccine Modeling Initiative (VMI)
The continuing morbidity and mortality associated with Staphylococcus aureus (S. aureus) infections, especially methicillin-resistant S. aureus (MRSA) infections, have motivated calls to make S. aureus vaccine development a research priority. We developed a decision analytic computer simulation model to determine the potential economic impact of a S. aureus vaccine for neonates. Our results suggest that a S. aureus vaccine for the neonatal population would be strongly cost-effective (and in many situations dominant) over a wide range of vaccine efficacies (down to 10%) for vaccine costs (<=$500), and S. aureus attack rates (>= 1%). (C) 2010 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据